To read this content please select one of the options below:

Viewpoint: cost-effective health care developments and research opportunities in China, India and Singapore

Jochen Wirtz (Department of Marketing, National University of Singapore, Queenstown, Singapore)
Chen Lin (School of Management, Fudan University, Shanghai, China)
Gopal Das (Indian Institute of Management Bangalore, Bangalore, India)

Journal of Services Marketing

ISSN: 0887-6045

Article publication date: 14 February 2022

Issue publication date: 7 June 2022

393

Abstract

Purpose

This study aims to show how major service developments in China, India and Singapore offer different perspectives on how cost-effective service excellence (CESE) can be achieved in health care. Resulting research opportunities are highlighted.

Design/methodology/approach

The study is based on the authors’ in-depth experience in these three countries.

Findings

Digital platforms and related technologies seem more advanced in China than in most western economies in terms of their application, user acceptance and market penetration. The resulting digital ecosystem enabled innovation that provides CESE in digital health care. Second, India benefitted from a large health care market without excessive regulation, litigation risks and interlocking stakeholders. These allowed a number of organizations to achieve CESE through new business models and frugal innovation. Likewise, Singapore is a global leader in health outcomes while it also has one of the lowest health care cost per capita. This is achieved through focus on costs and productivity, standardization and digitization while being intensely focused on health outcomes and the patient experience.

Research limitations/implications

The three countries stand out in the ways they achieved CESE in health care and offer interesting research opportunities. China has fully integrated digital platforms with rapid innovation capabilities, India has extremely high volumes that met focused service factory and frugal service innovation approaches, and Singapore is a tightly controlled health care market with high levels of discipline, both facilitated by its culture and small size. These markets invite research to explore their successes in more depth and deduct lessons for CESE in health care elsewhere.

Originality/value

Together, the author team has decades of managerial, executive teaching and research experience related to service in Asia. The observations and reflections in this study originate from this unique perspective.

Keywords

Acknowledgements

The authors gratefully acknowledge the following individuals for their valuable feedback to earlier drafts of this view point (in alphabetical order): Linda Alkire (Assistant Professor at Texas State University), Leonard L. Berry (University Distinguished Professor of Marketing at Texas A&M University), Dipu KV (President – Head Operations and Customer Service at Bajaj Allianz General Insurance), Dr. Amit Varma (Managing Partner, Quadria Capital) and Leon Wang (Executive Vice President, International and China President at AstraZeneca).

Citation

Wirtz, J., Lin, C. and Das, G. (2022), "Viewpoint: cost-effective health care developments and research opportunities in China, India and Singapore", Journal of Services Marketing, Vol. 36 No. 4, pp. 461-466. https://doi.org/10.1108/JSM-07-2021-0242

Publisher

:

Emerald Publishing Limited

Copyright © 2020, Emerald Publishing Limited

Related articles